Ren-Wang Peng is a Principal Investigator (PI) at the University Hospital of Bern (Inselspital) and Professor at the Faculty of Medicine, University of Bern, Switzerland, with research interests in basic and translational cancer research, in particular, the understanding of molecular mechanisms of therapy resistance and the mechanism-driven development of innovative strategies for the treatment of thoracic malignancies (lung cancer, mesothelioma). He received his PhD from the Chinese Academy of Sciences (CAS) in Beijing, China, and was a postdoctoral fellow and junior group leader at the Max Planck Institute for Biophysical Chemistry, Göttingen, Germany before becoming a group leader at the Swiss Federal Institute of Technology Zurich (ETH Zurich), Switzerland. Since 2012, he has been a PI and group leader at the University of Bern, Switzerland.
University of Bern
Bern, Switzerland